Not applicableStudy completedNCT01571934What this trial is testingInhibitor Development in Patients With Hemophilia A Undergoing SurgeryWho this might be right forHemophilia A Emory University 30
Post-approval studies (Phase 4)WithdrawnNCT00151385What this trial is testingStudy Evaluating Inhibitor Specificity in Hemophilia AWho this might be right forHemophilia A Wyeth is now a wholly owned subsidiary of Pfizer
Testing effectiveness (Phase 2)Ended earlyNCT05789537What this trial is testingSerpinPC in Participants with Hemophilia B (HemB) with InhibitorsWho this might be right forHemophilia B with InhibitorHemophilia B ApcinteX Ltd 3
Early research (Phase 1)Study completedNCT02270918What this trial is testingReversibility of Apixaban Anticoagulation With the Four Factor Prothrombin Complex Concentrate KcentraWho this might be right forThrombosis Thomas Jefferson University 12
Not applicableStudy completedNCT04165135What this trial is testingAn Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care TreatmentWho this might be right forSevere Hereditary Factor VIII Deficiency Disease Without InhibitorModerate Hereditary Factor VIII Deficiency Disease Without InhibitorHaemophilia A Hoffmann-La Roche 103
Very early researchStudy completedNCT04789954What this trial is testingStudy on the Dose-response Relationship of Pharmacodynamic Parameters in Patients With Hemophilia With InhibitorsWho this might be right forHemophilia A With InhibitorHemophilia B With Inhibitor AryoGen Pharmed Co. 14
Post-approval studies (Phase 4)Study completedNCT01800435What this trial is testingA Comparison Study of Bypassing Agent Therapy With and Without Tranexamic Acid in Haemophilia A Patients With InhibitorWho this might be right forHereditary Factor VIII Deficiency Disease With Inhibitor Oslo University Hospital 6
Not applicableNot Yet RecruitingNCT07200609What this trial is testingThe Effects of Virtual Reality-Based Gamified Rehabilitation in Children With HemophiliaWho this might be right forHemophilia A Without Inhibitor Hacettepe University 20
Testing effectiveness (Phase 2)UnknownNCT04592692What this trial is testingA Pharmacokinetic and Clotting Activity Study of FVIII-PEGLipWho this might be right forHemophilia A With Inhibitor Ascension Healthcare Development Limited 20
Testing effectiveness (Phase 2)Ended earlyNCT04548791What this trial is testingStudy of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding DisordersWho this might be right forFactor VII DeficiencyGlanzmann ThrombastheniaHemophilia A With Inhibitor Catalyst Biosciences 19
Post-approval studies (Phase 4)Looking for participantsNCT04647227What this trial is testingSEVENFACT® for Bleeding Events in Hemophilia With InhibitorsWho this might be right forHemophilia A With InhibitorHemophilia B With Inhibitor American Thrombosis and Hemostasis Network 55
Large-scale testing (Phase 3)Study completedNCT03417102What this trial is testingFitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With InhibitorsWho this might be right forHemophilia AHemophilia B Genzyme, a Sanofi Company 60
Early research (Phase 1)WithdrawnNCT03996486What this trial is testingStudy to Test the Safety of an Investigational Drug Given Repeatedly to Adult Men With Severe HemophiliaWho this might be right forHemophilia Bayer
Post-approval studies (Phase 4)Not Yet RecruitingNCT07158606What this trial is testingUnderstanding Treatment Outcomes and Immunologic Mechanisms in Altuviiio Immune Tolerance InductionWho this might be right forHemophilia A With Inhibitor Versiti Blood Health 15
Not applicableUnknownNCT02554526What this trial is testingBasic Study of Combination Therapy Based on APCC-induced FVllI Activation in Hemophilia A Patients With InhibitorsWho this might be right forHemophilia A With Inhibitor Nara Medical University 10
Early research (Phase 1)Study completedNCT04747964What this trial is testingA Safety Study of STSP-0601 in Adult Patients With Hemophilia A or B With InhibitorWho this might be right forHemophilia Staidson (Beijing) Biopharmaceuticals Co., Ltd 16
Large-scale testing (Phase 3)Study completedNCT03938792What this trial is testingStudy of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia BWho this might be right forHemophilia AHemophilia B Pfizer 189
Post-approval studies (Phase 4)UnknownNCT04621916What this trial is testingPreventing Inhibitor Recurrence IndefinitelyWho this might be right forHemophilia AImmune Tolerance Children's Hospital Los Angeles 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT04684940What this trial is testingSafety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior InhibitorsWho this might be right forHemophilia A With InhibitorHemophilia A With Anti Factor VIII BioMarin Pharmaceutical 10
Not applicableStudy completedNCT03951103What this trial is testingRFVIIIFc (Elocta®) ITI Chart Review in Patients With Haemophilia AWho this might be right forHemophilia A With Inhibitor Swedish Orphan Biovitrum 44